The iconic status of Viagra, and its parent firm copyright, presents a complex question for investors . While earnings initially surged, the impending patent lapse and increasing generic rivalry represent https://livianlwu557200.blogaritma.com/39374747/the-blue-pill-and-big-pharma-a-uncertain-investment